Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Pediatria
2014
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0021-75572014000100028 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0021-755720140001000282015-08-28Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trialKelishadi,RoyaSalek,ShadiSalek,MehdiHashemipour,MahinMovahedian,Mahsa Vitamin D Metabolic syndrome Insulin resistance Children and adolescents OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children. info:eu-repo/semantics/openAccessSociedade Brasileira de PediatriaJornal de Pediatria v.90 n.1 20142014-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028en10.1016/j.jped.2013.06.006 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Kelishadi,Roya Salek,Shadi Salek,Mehdi Hashemipour,Mahin Movahedian,Mahsa |
spellingShingle |
Kelishadi,Roya Salek,Shadi Salek,Mehdi Hashemipour,Mahin Movahedian,Mahsa Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
author_facet |
Kelishadi,Roya Salek,Shadi Salek,Mehdi Hashemipour,Mahin Movahedian,Mahsa |
author_sort |
Kelishadi,Roya |
title |
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
title_short |
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
title_full |
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
title_fullStr |
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
title_full_unstemmed |
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
title_sort |
effects of vitamin d supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial |
description |
OBJECTIVE: this triple-masked controlled trial aimed to assess the effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in obese children and adolescents. METHODS: the study comprised 50 participants, aged 10 to16 years, who were randomly assigned into two groups of equal number. In this 12-week trial, one group received oral vitamin D (300,000 IU) and the other group received placebo. Cardiometabolic risk factors, insulin resistance, and a continuous value of metabolic syndrome (cMetS) were determined. Statistical analysis was conducted after adjustment for covariate interactions. RESULTS: overall, 21 patients in the vitamin D group and 22 in the placebo group completed the trial. No significant difference was observed in the baseline characteristics of the two groups. After the trial, in the vitamin D group, serum insulin and triglyceride concentrations, as well as HOM -IR and C-MetS decreased significantly, both when compared with the baseline and with the placebo group. No significant difference was observed when comparing total cholesterol, LDL-C, HDL-C, fasting blood glucose, and blood pressure. CONCLUSION: the present findings support the favorable effects of vitamin D supplementation on reducing insulin resistance and cardiometabolic risk factors in obese children. |
publisher |
Sociedade Brasileira de Pediatria |
publishDate |
2014 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000100028 |
work_keys_str_mv |
AT kelishadiroya effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial AT salekshadi effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial AT salekmehdi effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial AT hashemipourmahin effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial AT movahedianmahsa effectsofvitamindsupplementationoninsulinresistanceandcardiometabolicriskfactorsinchildrenwithmetabolicsyndromeatriplemaskedcontrolledtrial |
_version_ |
1756375887868067840 |